Member Info for andrbea

hold, they say:

Https://www.proactiveinvestors.co.uk/companies/news/931348/greatland-gold-has-potential-to-add-even-more-value-from-paterson-acreage-broker-suggests-931348.html

ok, tks for the correction.

Oct 11
US working with the Netherlands

In one especially interesting development, the Energy Department has just launched a green H2 partnership with the Netherlands, with significant implications for grid resilience and renewable energy buildout as well as zero-emission mobility.

https://cleantechnica.com/2020/10/11/usas-100-million-green-hydrogen-fuel-cell-plan/

I see hydg is up 18% today

I can share the logic of first an rns to show you can self-manage manufacturing capacity, and then let the other rns's appear over sales updates/orders

from another board:
Currently Roche and Abbott have dominated the French testing market, however they have struggled to meet demands and some of their latest technology, such as the Abbott’s iD Now used to screen White House staff, could be missing as much as 30 to 50% of positive cases according to the FDA.

The best testing firm in town should be rising by 5 or10% a day, for the next month or so. Market (understandably depressed by Covid) is as blind as a bat. Value will out eventually, as their products are sorely needed, around the world.

With national lockdowns across Europe a pocsibility again, isn't gold destined to become a safe haven again, and rise steadily? Should benefit ggp IMO.

A care homes rollout could be worth £539m (I read earlier from a poster). which would exceed what we already have from the NHS......

if SAR can soar 59% today based on a Lupus connection to Covid, I would have thought that IMM would follow suite (an even closer connection here?)

HTTps://www.miragenews.com/immune-cell-activation-in-severe-covid-19-resembles-lupus/

A diagnostics company in the States called Quest Diagnostics has a pe ratio of 21.2. Its peers Lab Corp of America (pe of 53) and Fulgent Genetics (pe of 370) show just how low ncyt is valued . I look forward to a valuation by Numis, and what pe they choose.

About 15 years ago sar could rise 300% in a day, no trouble... :)

Still awaiting US sales update; care home trial outcome (UK) ... and France too
(from a poster on another thread):

HAS: 9 Oct 2020 (Haute Autorité de santé)

Translated...

High Authority of Health, France

"HAS continues to monitor the tests and sampling methods available or under development for the detection of SARS-CoV-2. It will update its work as soon as new data becomes available. In addition, it will rule next week on multiplex tests, that is to say those which aim to identify different viruses at the same time (SARS-CoV-2, influenza, other seasonal viruses)."

With a long Covid winter ahead, maybe total lockdown and depression cases rising, a perfect storm for a relaxing smoke indoors methinks. Smokables market should do well IMO.

As another poster said today:
A PE of 10, which is very low for a company experiencing exponential growth, would give short term SP target of £18 -£20.

or... ZOE

M&A example in the CBD sector: Oct 6 2020. Turning Point Brands Inc. (NYSE: TPB) has acquired a 20% stake in Wild Hemp, which will allow for national distribution of the company's Hempettes CBD cigarettes and potentially pave the way to a full acquisition of Wild Hemp given Turning Point Brands meets certain sales thresholds.
Https://www.bizjournals.com/louisville/news/2020/10/06/turning-point-brands-acquires-stake-in-hemp-cigar.html

The 500m(?) carrot keeps me in (the thought of):
old posts:

700 PCR contract are homes 583M

Darcy1: Care home test should have finished yesterday, how long before we get a contract for NPT in care homes, it could easily be as large as the contact they have just received

A: Saliva testing, Gov and Novacyt are running a trial in London and in Care Homes and result of that is due shortly. This is initiate Novacyt's national saliva test rollout and contract. Nova was one of the first to create a test which can detect LOW viral loads.

B: Care Homes. The Care Home rollout will be similar to the Hospital rollout we saw yesterday. Supply of Q32's and Q16's which can be used INSIDE the Care Home's all over the UK, by Bupa and other providers. Prof Martin is concluding as we speak. Nearly 22,000 Care Homes...

The 500m(?) carrot keeps me in (the thought of):
700 PCR contract care homes 583M

Da

great day:
Roche- supply problems, whereas ncyt doesn't
Roche brand blemished IMO - maybe a problem to for its supplies to the 120 countries of the WHO?

UK care home trial news, awaited & due
5 new products launched today at Microgen